Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05988619 · ClinicalTrials.gov registry record · NA
iCBT With TMS in Patients With MDD
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT05988619 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 40 participants.
The verdict
NCT05988619, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
Major Depressive Disorder (MDD) is a common mental health diagnosis. While there are many approaches to the treatment of MDD, current treatments of MDD often do not substantially reduce depressive symptoms among those in need of care. Prior research suggests that combining cognitive-behavioral therapy (CBT) and psychopharmacology can produce optimal treatment outcomes compared to the use of either treatment individually. Transcranial Magnetic Stimulation (TMS) is one promising brain stimulation approach used to treat MDD, especially among patients with treatment-resistant symptoms. Like psychopharmacological interventions, TMS may produce optimal treatment outcomes when paired with CBT. However, standard TMS protocols are time-intensive, typically requiring daily doctor visits for one hour of six to eight weeks. Therefore, an internet-delivered CBT protocol may augment the effects of TMS without substantially increasing patient burden. To that end, the present study assesses if a combined TMS and internet-delivered CBT protocol may produce superior treatment outcomes compared with TMS alone.
Interventions
- BEHAVIORAL Psychoeducation
- DEVICE Transcranial Magnetic Stimulation
- BEHAVIORAL Internet-Based Cognitive Behavioral Therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2021-03-21 |
| Est. Completion | 2024-09-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05988619
The ClinicalTrials.gov registry entry for NCT05988619 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Psychoeducation is the first listed.
NCT05988619 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05988619 about?
NCT05988619 is a clinical study titled "iCBT With TMS in Patients With MDD". Major Depressive Disorder (MDD) is a common mental health diagnosis. While there are many approaches to the treatment of MDD, current treatments of MDD often do not substantially reduce depressive symptoms among those in need of care. Prior research suggests that combining cognitive-behavioral thera...
What is the current status of trial NCT05988619?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2021-03-21. Estimated completion is 2024-09-07.
What interventions are being tested in trial NCT05988619?
The interventions under investigation include: Psychoeducation (BEHAVIORAL), Transcranial Magnetic Stimulation (DEVICE), Internet-Based Cognitive Behavioral Therapy (BEHAVIORAL).
Who is sponsoring clinical trial NCT05988619?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.